Shinichi Nomoto

Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.

T. Shimizu, H. Echizen, S. Nomoto, 1998, Pharmacogenetics.